Term ends Feb 14, 2040 · Low confidence
20-year base term ends Feb 14, 2040
Held by Metagenomi Therapeutics, Inc.
Filed Jun 30, 2020 as application 16/917,838 · Granted Feb 9, 2021
Base term, 20 years from filing
Today
2020
2040
Clock starts
Feb 14, 2020
Feb 14, 2020
Term ends
Feb 14, 2040
Feb 14, 2040
Granted
Feb 9, 2021
Feb 9, 2021
base term
fee events
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,982,200, to Feb 14, 2040. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 14, 2020, when application PCT/US2020/018432, the earliest non-provisional in its chain, was filed (this one was filed Jun 30, 2020); a parent in its chain could not be resolved (the next row) | Feb 14, 2040 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,982,200) | resolves to Feb 14, 2040, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: PCTUS2020018432 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Feb 14, 2040 | Low confidence |
This family
| Application PCT/US2020/018432 | PCT application no patent term | no patent term |
| US 10,982,200 | In force Feb 2040 | Feb 2040 |
| US 10,913,941 | this patent Feb 2040 | Feb 2040 |
| US 12,024,727 | In force Feb 2040 | Feb 2040 |
| Application PCT/US2021/031136 | PCT application no patent term | no patent term |
| Application 17/402,426 | Pending not computed | not computed |
| Application 18/053,232 | Pending not computed | not computed |
| US 12,735,688 | In force May 2040 | May 2040 |
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 6, 2020 Reel 53425, frame 298 | Thomas, Brian; Brown, Christopher; Kantor, Rose; Devoto, Audra; Butterfield, Cristina; Alexander, Lisa; Goltsman, Daniela S.a.; Liu, Jason | Metagenomi IP Technologies, LLC | Assignment of Assignor's Interest |
| Apr 26, 2022 Reel 60377, frame 687 | Thomas, Brian; Brown, Christopher; Kantor, Rose; Devoto, Audra; Butterfield, Cristina; Alexander, Lisa; Goltsman, Daniela S.a.; Liu, Jason | Metagenomi, Inc. | Corrective Assignment to Correct the Assignee's Name and Address Previously Recorded at Reel: 053425 Frame: 0298. Assignor(S) Hereby Confirms the Assignment. |
| Sep 12, 2022 Reel 61410, frame 63 | Metagenomi, Inc. | Metagenomi IP Technologies, LLC | Assignment of Assignor's Interest |
| Oct 11, 2022 Reel 61383, frame 584 | Metagenomi IP Technologies, LLC | Metagenomi, Inc. | Merger |
| Mar 4, 2025 Reel 70403, frame 862 | Affini-T Therapeutics, Inc. | Catalio Nexus Fund III, LP | Security Interest |
| Dec 12, 2025 Reel 73201, frame 168 | Catalio Nexus Fund III, LP | Affini-T Therapeutics, Inc. | Release of Security Interest |
| Feb 6, 2026 Reel 73717, frame 149 | Metagenomi, Inc. | Metagenomi Therapeutics, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2040
Term ends Feb 14, 2040. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,982,200, ends no earlier than this term, so it caps nothing.
Citations
10
later US patents cite this one
That is top 25% of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.